FP
CMD

Foundry Partners’s Cantel Medical Corporation CMD Stock Holding History

Foundry Partners’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14,590
Closed -$1.03M – 431
2019
Q4 		$1.03M Sell
14,590
-7,016
-32% -$509K 0.04% 319
2019
Q3 		$1.62M Sell
21,606
-51
-0.2% -$4.32K 0.07% 280
2019
Q2 		$1.75M Sell
21,657
-64
-0.3% -$4.5K 0.07% 275
2019
Q1 		$1.45M Sell
21,721
-1,415
-6% -$107K 0.06% 295
2018
Q4 		$1.72M Sell
23,136
-39
-0.2% -$3.22K 0.08% 285
2018
Q3 		$2.13M Sell
23,175
-5,303
-19% -$505K 0.08% 279
2018
Q2 		$2.8M Sell
28,478
-1,830
-6% -$205K 0.11% 247
2018
Q1 		$3.38M Sell
30,308
-59
-0.2% -$6.61K 0.14% 215
2017
Q4 		$3.12M Sell
30,367
-23,810
-44% -$2.37M 0.13% 223
2017
Q3 		$5.1M Sell
54,177
-158
-0.3% -$12.5K 0.2% 187
2017
Q2 		$4.23M Sell
54,335
-2,087
-4% -$157K 0.17% 204
2017
Q1 		$4.52M Buy
56,422
+718
+1% +$57.1K 0.19% 201
2016
Q4 		$4.39M Buy
+55,704
New +$4.33M 0.19% 201

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Foundry Partners's CMD Position: Q1 2020 in Review

Foundry Partners sold out of Cantel Medical Corporation (CMD) in Q1 2020, closing a stake of 14,590 shares — an estimated $1.03M sold.

Foundry Partners first reported a position in CMD in Q4 2016 and held it in 13 quarters. The position peaked at $5.1M in Q3 2017. 213 funds tracked by Wall St. Rank hold CMD as of Q1 2020.

  • Foundry Partners reported no remaining Cantel Medical Corporation position as of Q1 2020 after selling out during the quarter.
  • Foundry Partners sold 14,590 Cantel Medical Corporation shares in Q1 2020, an estimated $1.03M.
  • Foundry Partners first reported a position in Cantel Medical Corporation in Q4 2016 and held it in 13 quarters.
  • Foundry Partners's Cantel Medical Corporation position peaked at $5.1M in Q3 2017.
  • 213 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2020.

Based on Foundry Partners's 13F filing for Q1 2020, filed 8 May 2020.